Literature DB >> 21744264

Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes.

Alireza Esteghamati1, Nasrin Mansournia, Manouchehr Nakhjavani, Mohammad Ali Mansournia, Abdolrahim Nikzamir, Mehrshad Abbasi.   

Abstract

The relation of Two single nucleotide polymorphisms (SNPs) at the adiponectin locus (+45T/G and +276G/T) with coronary artery disease (CAD) is controversial. The aim of the present study was to evaluate the genetic influence of the adiponectin gene polymorphisms in the development of CAD among patients with Type 2 diabetes (T2D). The adiponectin genotypes were detected by polymerase chain reaction and restriction analysis (PCR-RFLP) in our patients. Two adiponectin gene (ADIPOQ) SNPs (i.e. SNPs +45T>G and +276G>T) were genotyped in 114 Type 2 diabetic subjects with CAD, and 127 Type 2 diabetic patients without CAD. Demographic and anthropometric data along with plasma biochemistry including lipids, glycemic indices, and adiponectin were collected. There was a significant difference in the distribution of genotypes of +45T/G and +276G/T between CAD and non-CAD individuals (P < 0.05). Based on our results SNP+276G>T is associated with decreased risk of CAD after adjustment for potential confounding factors [adjusted OR = 0.39 (95%CI: 0.22-0.68); P = 0.001]. Similar findings were not observed for the +45T>G SNP. Two haplotypes 45T-276T and 45G-276T were associated with a decreased risk of CAD [adjusted OR = 0.47 (95% CI: 0.32-0.94); P = 0.03 and adjusted OR = 0.33 (95% CI: 0.13-0.83); P = 0.02 respectively]. No significant difference was observed between HOMA-IR, BMI, waist circumference, history of hypertension, HbA1C, and lipid concentrations regarding the two SNPs. In conclusion, these findings suggest that T allele of +276G>T SNP is significantly associated with decreased risk of CAD in T2D Patients. Also Haplotype analysis showed that two haplotypes 45T-276T and 45G-276T were associated with a decreased risk of CAD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744264     DOI: 10.1007/s11033-011-1156-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  9 in total

1.  The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome.

Authors:  A G Comuzzie; T Funahashi; G Sonnenberg; L J Martin; H J Jacob; A E Black; D Maas; M Takahashi; S Kihara; S Tanaka; Y Matsuzawa; J Blangero; D Cohen; A Kissebah
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

Review 2.  The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.

Authors:  G Frühbeck; J Gómez-Ambrosi; F J Muruzábal; M A Burrell
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-06       Impact factor: 4.310

3.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

Authors:  K Maeda; K Okubo; I Shimomura; T Funahashi; Y Matsuzawa; K Matsubara
Journal:  Biochem Biophys Res Commun       Date:  1996-04-16       Impact factor: 3.575

4.  Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

Authors:  C Weyer; T Funahashi; S Tanaka; K Hotta; Y Matsuzawa; R E Pratley; P A Tataranni
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

5.  C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer.

Authors:  Liping Qiao; Paul S Maclean; Jerome Schaack; David J Orlicky; Christian Darimont; Michael Pagliassotti; Jacob E Friedman; Jianhua Shao
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

6.  Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma.

Authors:  Y Nakano; T Tobe; N H Choi-Miura; T Mazda; M Tomita
Journal:  J Biochem       Date:  1996-10       Impact factor: 3.387

7.  Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease.

Authors:  Gianluca Iacobellis; Daniela Pistilli; Marco Gucciardo; Frida Leonetti; Fabio Miraldi; Gianluca Brancaccio; Pietro Gallo; Cira Rosaria Tiziana di Gioia
Journal:  Cytokine       Date:  2005-03-21       Impact factor: 3.861

8.  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Authors:  J Stamler; O Vaccaro; J D Neaton; D Wentworth
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

9.  AdipoQ is a novel adipose-specific gene dysregulated in obesity.

Authors:  E Hu; P Liang; B M Spiegelman
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

  9 in total
  14 in total

1.  The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.

Authors:  Maryam Moini; Fatemeh Ghaderi; Mohamad Mehdi Sagheb; Ali Reza Tavasolli; Negar Azarpira; Masumeh Darai; Bita Geramizadeh
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

2.  Vascular endothelial growth factor (VEGF) +405 C/G polymorphism is associated with essential hypertension in a population from Tehran of Iran.

Authors:  Amir Abbas Hamedian; Alireza Esteghamati; Sina Noshad; Mohammad Mozafari; Hosein Moin-Tavakkoli; Manouchehr Nakhjavani; Touraj Mahmoudi; Mahfam Nikzamir; Reza Safary; Abdolrahim Nikzamir
Journal:  Mol Biol Rep       Date:  2011-12-31       Impact factor: 2.316

3.  Haplotype TGTG from SNP 45T/G and 276G/T of the adiponectin gene contributes to risk of polycystic ovary syndrome.

Authors:  S Radavelli-Bagatini; I O de Oliveira; R B Ramos; B R Santos; M S Wagner; S B Lecke; D P Gigante; B L Horta; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

4.  Contribution of adiponectin polymorphisms to the risk of coronary artery disease in a North-African Tunisian population.

Authors:  Lakhdar Ghazouani; Afoua Elmufti; Intissar Baaziz; Ibtissem Chaabane; Hedi Ben Mansour
Journal:  J Clin Lab Anal       Date:  2018-04-06       Impact factor: 2.352

5.  Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis.

Authors:  Huan Zhang; Xingbo Mo; Yongchen Hao; Dongfeng Gu
Journal:  BMC Med Genet       Date:  2012-05-28       Impact factor: 2.103

6.  Association of two Common Single Nucleotide Polymorphisms (+45T/G and +276G/T) of ADIPOQ Gene with Coronary Artery Disease in Type 2 Diabetic Patients.

Authors:  Ghorban Mohammadzadeh; Mohammad-Ali Ghaffari; Habib Heibar; Mohammad Bazyar
Journal:  Iran Biomed J       Date:  2016-01-19

7.  Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case-control study.

Authors:  Joseph Sam Kanu; Yulu Gu; Sun Zhi; Mingxi Yu; Yuping Lu; Yetong Cong; Yunkai Liu; Yong Li; Yaqin Yu; Yi Cheng; Yawen Liu
Journal:  Lipids Health Dis       Date:  2016-01-12       Impact factor: 3.876

Review 8.  Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies.

Authors:  Mehrnoosh Khodaeian; Samaneh Enayati; Ozra Tabatabaei-Malazy; Mahsa M Amoli
Journal:  J Diabetes Res       Date:  2015-10-26       Impact factor: 4.011

9.  Single Nucleotide Polymorphism (SNP) in the Adiponectin Gene and Cardiovascular Disease.

Authors:  Salvatore Chirumbolo
Journal:  Iran Biomed J       Date:  2016-02-17

Review 10.  Associations between two common single nucleotide polymorphisms (rs2241766 and rs1501299) of ADIPOQ gene and coronary artery disease in type 2 diabetic patients: a systematic review and meta-analysis.

Authors:  Na Zhao; Ningxia Li; Shengjun Zhang; Qiang Ma; Cong Ma; Xiaolan Yang; Jie Yin; Rui Zhang; Jing Li; Xiaogang Yang; Tao Cui
Journal:  Oncotarget       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.